September 10, 2020

The Underdog Coronavirus Vaccines That The World Will Need If Front Runners Stumble-Nature

As leading pharmaceutical and biotechnology companies speed their COVID-19 vaccines through clinical trials and eye up fast-track regulatory authorization, dozens of underdog vaccines have stalled, or are advancing along a slower, more conventional path. Scientists acknowledge that it would be a waste of resources to take every candidate to clinical trials. But they argue that it’s essential to have a diverse selection of COVID-19 vaccines in development. Nature, 09/09/2020